Fej-nyaki daganatok: vizsgálatok itt: Kína
217 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleSpecialist Nurse-Led Nursing Management for Patients Undergoing Head and Neck Cancer Surgery
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 80
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07622381 - 1/2. fázisTaking peopleEGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- Beijing Biotech
See details and how to joinNCT07617805 - 2. fázisCsak meghívásosBRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression
- Where
- Foshan, Guangzhou, Shantou, Shenzhen, Zhanjiang
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- Sun Yat-sen University
See details and how to joinNCT07618624 - 2/3. fázisTaking peopleTrop2-targeted immunoPET Imaging of Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 400
- Run by
- RenJi Hospital
See details and how to joinNCT06851663 - 3. fázisTaking peopleA Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- Where
- Baoding, Beijing, Changsha, Changzhou, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Hefei, Hengyang, Jinan, Kunming, Lanzhou, Linyi, Nanchang, Nanning, Nanyang, Shanghai, Taiyuan, Wuhan, Xiamen, Xuzhou, Zhengzhou, Zhuhai
- Életkor
- 18 év and over
- People
- 864 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06256588 · EU 2023-508613-17-00 - 1/2. fázisNot yet taking people in KínaTreatment of Recurrent/Metastatic Head and Neck Cancer
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Nanning, Shenyang, Taiyuan, Tianjin, Wuhan
- Életkor
- 18 év to 75 év
- People
- 128
- Run by
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
See details and how to joinNCT07601204 - 2. fázisNot yet taking people in KínaBecotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study
- Where
- Foshan, Ganzhou, Guangzhou, Qingyuan, Shantou, Shenzhen, Zhanjiang
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- Sun Yat-sen University
See details and how to joinNCT07589049 - No phaseTaking people18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 200
- Run by
- Peking University First Hospital
See details and how to joinNCT07557225 - 2. fázisTaking peopleNeoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 30
- Run by
- West China Hospital
See details and how to joinNCT07492914 - 1. fázisNot yet taking people in KínaA Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 192
- Run by
- Corregene Biotechnology Co., Ltd
See details and how to joinNCT07583316 - 1. fázisTaking peoplePhase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
- Where
- Guangzhou
- Életkor
- 2 év to 18 év
- People
- 51
- Run by
- Sun Yat-sen University
See details and how to joinNCT07584499 - 1. fázisTaking peopleFinotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Beijing Tongren Hospital
See details and how to joinNCT07040072 - No phaseTaking peopleA Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.
- Where
- Guangzhou
- Életkor
- 20 év to 70 év
- People
- 524
- Run by
- Jinsong Hou
See details and how to joinNCT02743832 - 2. fázisNot yet taking people in KínaIparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC
- Where
- Nanchang
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07041788 - 1. fázisTaking peopleRe-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy
- Where
- Chengdu
- Életkor
- 18 év to 75 év
- People
- 6
- Run by
- West China Hospital
See details and how to joinNCT07545967 - 2. fázisNot yet taking people in KínaNeoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 36
- Run by
- Chen Chunyan
See details and how to joinNCT07554768 - No phaseTaking peopleClinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 32
- Run by
- Grit Biotechnology
See details and how to joinNCT06190275 - 2. fázisCsak meghívásosNeoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT07550972 - No phaseTaking peopleA Study Investigating the Efficacy and Safety of the Combination of Iparomlimab and Tuvonralimab With or Without Chemotherapy in Second-line and Subsequent Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Where
- Haikou
- Életkor
- 18 év to 75 év
- People
- 32
- Run by
- The Second Affiliated Hospital of Hainan Medical University
See details and how to joinNCT07546383 - 3. fázisTaking peoplePostoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 370
- Run by
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07445048 - No phaseTaking peopleROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer
- Where
- Chengdu
- Életkor
- 18 év to 80 év
- People
- 40
- Run by
- West China Hospital
See details and how to joinNCT07081074 - No phaseTaking peopleROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer
- Where
- Chengdu
- Életkor
- 18 év to 80 év
- People
- 5
- Run by
- West China Hospital
See details and how to joinNCT07086638 - 3. fázisTaking peopleBecotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPS≥1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Zhuhai
- Életkor
- 18 év to 75 év
- People
- 430
- Run by
- Ming-Yuan Chen
See details and how to joinNCT07524452 - 1/2. fázisTaking peopleA Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Where
- Changchun, Changsha, Chengdu, Nanjing, Shanghai, Shenyang, Wuxi, Zhengzhou
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05785741 - No phaseTaking peopleTopical Diclofenac for Prevention of Radiation-induced Dermatitis
- Where
- Haikou
- Életkor
- 18 év to 75 év
- People
- 156
- Run by
- The Second Affiliated Hospital of Hainan Medical University
See details and how to joinNCT06905561